Chemoinformaics analysis of Heliotridine, 7,9-ditiglate
| Molecular Weight | 319.401 | nRot | 5 |
| Heavy Atom Molecular Weight | 294.201 | nRig | 13 |
| Exact Molecular Weight | 319.178 | nRing | 2 |
| Solubility: LogS | -2.341 | nHRing | 2 |
| Solubility: LogP | 2.627 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 48 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 25 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 51.0378 |
| nHD | 0 | BPOL | 31.9982 |
| QED | 0.442 |
| Synth | 4.004 |
| Natural Product Likeliness | 2 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.988 |
| Pgp-sub | 0.003 |
| HIA | 0.006 |
| CACO-2 | -4.47 |
| MDCK | 0.0000303 |
| BBB | 0.879 |
| PPB | 0.597285 |
| VDSS | 2.103 |
| FU | 0.376824 |
| CYP1A2-inh | 0.372 |
| CYP1A2-sub | 0.365 |
| CYP2c19-inh | 0.742 |
| CYP2c19-sub | 0.693 |
| CYP2c9-inh | 0.412 |
| CYP2c9-sub | 0.124 |
| CYP2d6-inh | 0.934 |
| CYP2d6-sub | 0.349 |
| CYP3a4-inh | 0.712 |
| CYP3a4-sub | 0.447 |
| CL | 13.298 |
| T12 | 0.861 |
| hERG | 0.029 |
| Ames | 0.088 |
| ROA | 0.139 |
| SkinSen | 0.73 |
| Carcinogencity | 0.928 |
| EI | 0.266 |
| Respiratory | 0.861 |
| NR-Aromatase | 0.027 |
| Antiviral | Yes |
| Prediction | 0.844063 |